| MolName | 2-[4-[(Z)-[2,4-dioxo-3-(2-oxo-2-piperidin-1-ylethyl)-1,3-thiazolidin-5-ylidene]methyl]phenoxy]-N-phenylacetamide |
| MolecularFormula | C25H25N3O5S |
| Smiles | O=C(COc1ccc(/C=C(/C(N2CC(N3CCCCC3)=O)=O)\SC2=O)cc1)Nc1ccccc1 |
| InChI | InChI=1S/C25H25N3O5S/c29-22(26-19-7-3-1-4-8-19)17-33-20-11-9-18(10-12-20)15-21-24(31)28(25(32)34-21)16-23(30)27-13-5-2-6-14-27/h1,3-4,7-12,15H,2,5-6,13-14,16-17H2,(H,26,29) |
| InChIK | HPMUUVRSQWESOI-UHFFFAOYSA-N |
| TotalMolweight | 479.556 |
| Molweight | 479.556 |
| MonoisotopicMass | 479.151492 |
| CLogP | 2.9479 |
| CLogS | -4.44 |
| H Acceptors | 8 |
| H Donors | 1 |
| TotalSurfaceArea | 357.6 |
| Relative PSA | 0.27464 |
| PolarSurfaceArea | 121.32 |
| Druglikeness | 3.4974 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | limit! methylene-thiazolidine-2,4-dione |
| Shape Index | 0.64706 |
| Fragments | 1 |
| Non HAtoms | 34 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| Rotatable Bond | 7 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 9 |
| Symmetricatoms | 6 |
| Amides | 3 |
| StereoCon |
Click to Load Molecule:
1 - 2-[4-[(Z)-[2,4-dioxo-3-(2-oxo-2-piperidin-1-ylethyl)-1,3-thiazolidin-5-ylidene]methyl]phenoxy]-N-phenylacetamide | 2 - 2-[4-[(Z)-[2,4-dioxo-3-(2-oxo-2-piperidin-1-ylethyl)-1,3-thiazolidin-5-ylidene]methyl]phenoxy]-N-phenylacetamide